πΊπΈ
United States Β· US Β· US:0074-1044_998985bb-7cd1-4e80-bd08-8fc7c503f982
EMRELIS
UNIISPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAbbVie Inc.
CountryUS (United States)
ATC codeβ
Dispensingβ
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs Β· 1
- ndc1100741044011 VIAL, SINGLE-DOSE in 1 CARTON (0074-1044-01) / 1 mL in 1 VIAL, SINGLE-DOSE
Annotations
UNII (FDA Substance ID)
976X9VXC3Z
TELISOTUZUMAB VEDOTIN
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "976X9VXC3Z",
"rxcui": null,
"inchikey": null,
"display_name": "TELISOTUZUMAB VEDOTIN",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"bc04f980-3957-4e35-ab81-8ec2ffe87215": {
"match": "brand_token",
"title": "EMRELIS (TELISOTUZUMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ABBVIE INC.]",
"spl_version": "3",
"published_date": "2025-07-10"
}
},
"productid": "0074-1044_998985bb-7cd1-4e80-bd08-8fc7c503f982",
"productndc": "0074-1044",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "TELISOTUZUMAB VEDOTIN",
"proprietary_name": "EMRELIS",
"active_ingred_unit": "mg/mL",
"application_number": "BLA761384",
"marketing_category": "BLA",
"nonproprietary_name": "Telisotuzumab Vedotin",
"start_marketing_date": "20250514",
"active_numerator_strength": "20"
}Access this data programmatically
Query EMRELIS and 610,000+ other drug records through a single REST API β with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.